-
1دورية أكاديمية
المؤلفون: Motzer R., Alekseev B., Rha S. -Y., Porta C., Eto M., Powles T., Grunwald V., Hutson T. E., Kopyltsov E., Mendez-Vidal M. J., Kozlov V., Alyasova A., Hong S. -H., Kapoor A., Gordoa T. A., Merchan J. R., Winquist E., Maroto P., Goh J. C., Kim M., Gurney H., Patel V., Peer A., Procopio G., Takagi T., Melichar B., Rolland F., de Giorgi U., Wong S., Bedke J., Schmidinger M., Dutcus C. E., Smith A. D., Dutta L., Mody K., Perini R. F., Xing D., Choueiri T. K., Boccardo F.
المساهمون: Motzer, R., Alekseev, B., Rha, S. -Y., Porta, C., Eto, M., Powles, T., Grunwald, V., Hutson, T. E., Kopyltsov, E., Mendez-Vidal, M. J., Kozlov, V., Alyasova, A., Hong, S. -H., Kapoor, A., Gordoa, T. A., Merchan, J. R., Winquist, E., Maroto, P., Goh, J. C., Kim, M., Gurney, H., Patel, V., Peer, A., Procopio, G., Takagi, T., Melichar, B., Rolland, F., de Giorgi, U., Wong, S., Bedke, J., Schmidinger, M., Dutcus, C. E., Smith, A. D., Dutta, L., Mody, K., Perini, R. F., Xing, D., Choueiri, T. K., Boccardo, F.
مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Antineoplastic Agent, Antineoplastic Combined Chemotherapy Protocol, Carcinoma, Renal Cell, Everolimu, Female, Human, Kidney Neoplasm, Male, Middle Aged, Phenylurea Compound, Programmed Cell Death 1 Receptor, Progression-Free Survival, Protein Kinase Inhibitor, Quinoline, Sunitinib, Survival Analysis
وصف الملف: ELETTRONICO
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33616314; info:eu-repo/semantics/altIdentifier/wos/WOS:000637799800007; volume:384; firstpage:1289; lastpage:1300; numberofpages:12; journal:NEW ENGLAND JOURNAL OF MEDICINE; http://hdl.handle.net/11567/1046356Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85103105017
-
2دورية أكاديمية
المؤلفون: Motzer R., Alekseev B., Rha S. -Y., Porta C., Eto M., Powles T., Grunwald V., Hutson T. E., Kopyltsov E., Mendez-Vidal M. J., Kozlov V., Alyasova A., Hong S. -H., Kapoor A., Gordoa T. A., Merchan J. R., Winquist E., Maroto P., Goh J. C., Kim M., Gurney H., Patel V., Peer A., Procopio G., Takagi T., Melichar B., Rolland F., de Giorgi U., Wong S., Bedke J., Schmidinger M., Dutcus C. E., Smith A. D., Dutta L., Mody K., Perini R. F., Xing D., Choueiri T. K.
المساهمون: Motzer, R., Alekseev, B., Rha, S. -Y., Porta, C., Eto, M., Powles, T., Grunwald, V., Hutson, T. E., Kopyltsov, E., Mendez-Vidal, M. J., Kozlov, V., Alyasova, A., Hong, S. -H., Kapoor, A., Gordoa, T. A., Merchan, J. R., Winquist, E., Maroto, P., Goh, J. C., Kim, M., Gurney, H., Patel, V., Peer, A., Procopio, G., Takagi, T., Melichar, B., Rolland, F., de Giorgi, U., Wong, S., Bedke, J., Schmidinger, M., Dutcus, C. E., Smith, A. D., Dutta, L., Mody, K., Perini, R. F., Xing, D., Choueiri, T. K.
مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Antineoplastic Agent, Antineoplastic Combined Chemotherapy Protocol, Carcinoma, Renal Cell, Everolimu, Female, Human, Kidney Neoplasm, Male, Middle Aged, Phenylurea Compound, Programmed Cell Death 1 Receptor, Progression-Free Survival, Protein Kinase Inhibitor, Quinoline, Sunitinib, Survival Analysis
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33616314; info:eu-repo/semantics/altIdentifier/wos/WOS:000637799800007; volume:384; issue:14; firstpage:1289; lastpage:1300; numberofpages:12; journal:NEW ENGLAND JOURNAL OF MEDICINE; http://hdl.handle.net/11586/369384Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85103105017
-
3دورية أكاديمية
المؤلفون: Powles T., van der Heijden M. S., Castellano D., Galsky M. D., Loriot Y., Petrylak D. P., Ogawa O., Park S. H., Lee J. -L., De Giorgi U., Bogemann M., Bamias A., Eigl B. J., Gurney H., Mukherjee S. D., Fradet Y., Skoneczna I., Tsiatas M., Novikov A., Suarez C., Fay A. P., Duran I., Necchi A., Wildsmith S., He P., Angra N., Gupta A. K., Levin W., Bellmunt J., Lee J. L., Westgeest H., Flechon A., Ou Y. -C., Park I., Matveev V., Perez-Valderrama B., Cheng S., Frank S., Anido U., Hamzaj A., Retz M., Sridhar S., Scagliotti G. V., Voortman J., Alekseev B., Alyasova A., Komyakov B., Dumez H., Pavic M., Kimura G., Mizokami A., Osanto S., Arranz J. A., Piersma D., Shin S. J., Karyakin O., Delgado I., Gonzalez J. L., Pang S. -T., Tran A., Lipatov O., Su W. -P., Flaig T., Alva A., Park Kyong H., Kopyltsov E., Almagro E., Domenech M., Chang Y. -H., Sautois B., Ravaux A., Aravantinos G., Georgoulias V., Mulder S., Kim Y. J., Kater F., Chevreau C., Tagawa S., Zalewski P., Joly F., Hatiboglu G., Gianni L., Morelli F., Tambaro R., Hashimoto Y., Nosov A., Font A., Rodriguez-Vida A. M., Jones R., Vasudev N., Srinivas S., Zhang J., Gil T., Finch D., Grimm M. -O., Su Y. -L., Chowdhury S., Hocking C., Plas E., North S., Jensen N. V., Theodore C., Imkamp F., Peer A., Kobayashi T., Sakai H., Sassa N., Yoshimura K., Aarts M., Ferreira Castro A., Topuzov M., Rodriguez J. F., Vazquez F. J., Tsai Y. -C., Crabb S., Hussain S., Bendell J., Gross-Goupil M., Gwenaelle G., Berger R., Statsenko G., Evans L., Drakaki A., Somer B., Davis I., Lynam J., Borges G., Dettino A., Martins G., Zucca L. E., Agerbaek M., Kalofonos H., Rosenbaum E., Enokida H., Kikukawa H., Nishimura K., Tamada S., Uemura M., Lopez Y., Gietema J., Slojewski M., Fernandes I., Smolin A., Mazhar D., Kalebasty A. R., Carthon B., Loidl W., Franke F., Girotto G., Alimohamed N., Macfarlane R., Pappot H., Niegisch G., Mavroudis D., Sella A., Porta C., Ebara S., Nakamura M., Obara W., Okuno N., Shinohara N., Sugimoto M., Suzuki A., Tokuda N., Uemura H., Yamaguchi A., Ramirez F., Rozanowski P., Wiechno P., Keam B., Kislov N., Plaksin D., Cicin I., Kumar S., Rosales J., Vaishampayan U., Culine S., Papandreou C., Nara T., Erman M., Kreiger L., Janoski J., Rosa D., Siqueira M., Canil C., Sengelov L., Tourani J. -M., Arai G., Hashine K., Kawakita M., Nakaigawa N., Nomi H., Shiina H., Suzuki H., Yonese J., Kuri R., Macedo E., Rivera S., Villalobos Prieto A., Polakiewicz-Gilowska A., Zaucha R., Lopes F., Ponomarev R., Pomerantz M., Shariat S., Luk C., Lesniewski-Kmak K.
المساهمون: Powles, T., van der Heijden, M. S., Castellano, D., Galsky, M. D., Loriot, Y., Petrylak, D. P., Ogawa, O., Park, S. H., Lee, J. -L., De Giorgi, U., Bogemann, M., Bamias, A., Eigl, B. J., Gurney, H., Mukherjee, S. D., Fradet, Y., Skoneczna, I., Tsiatas, M., Novikov, A., Suarez, C., Fay, A. P., Duran, I., Necchi, A., Wildsmith, S., He, P., Angra, N., Gupta, A. K., Levin, W., Bellmunt, J., Lee, J. L., Westgeest, H., Flechon, A., Ou, Y. -C., Park, I., Matveev, V., Perez-Valderrama, B., Cheng, S., Frank, S., Anido, U., Hamzaj, A., Retz, M., Sridhar, S., Scagliotti, G. V., Voortman, J., Alekseev, B., Alyasova, A., Komyakov, B., Dumez, H., Pavic, M., Kimura, G., Mizokami, A., Osanto, S., Arranz, J. A., Piersma, D., Shin, S. J., Karyakin, O., Delgado, I., Gonzalez, J. L., Pang, S. -T., Tran, A., Lipatov, O., Su, W. -P., Flaig, T., Alva, A., Park Kyong, H., Kopyltsov, E., Almagro, E., Domenech, M., Chang, Y. -H., Sautois, B., Ravaux, A., Aravantinos, G., Georgoulias, V., Mulder, S., Kim, Y. J., Kater, F., Chevreau, C., Tagawa, S., Zalewski, P., Joly, F., Hatiboglu, G., Gianni, L., Morelli, F., Tambaro, R., Hashimoto, Y., Nosov, A., Font, A., Rodriguez-Vida, A. M., Jones, R., Vasudev, N., Srinivas, S., Zhang, J., Gil, T., Finch, D., Grimm, M. -O., Su, Y. -L.
مصطلحات موضوعية: Aged, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, Antineoplastic Combined Chemotherapy Protocol, Carcinoma, Female, Human, Immune Checkpoint Inhibitor, Male, Middle Aged, Time Factor, Treatment Outcome, Urologic Neoplasm, Urothelium
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32971005; info:eu-repo/semantics/altIdentifier/wos/WOS:000599899200041; volume:21; issue:12; firstpage:1574; lastpage:1588; numberofpages:15; journal:THE LANCET ONCOLOGY; http://hdl.handle.net/11586/389577Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85091519786
الإتاحة: https://doi.org/10.1016/S1470-2045Test(20)30541-6
http://hdl.handle.net/11586/389577Test